B38.89
Other forms of coccidioidomycosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Coccidioidomycosis, commonly known as Valley fever, is a fungal infection caused by Coccidioides species. While most cases involve the lungs, some individuals develop unusual or less typical presentations. These are classified under 'Other forms of coccidioidomycosis' with the ICD-10 code B38.89. This category encompasses a variety of less common or atypical manifestations that can affect different parts of the body. Recognizing these forms is crucial for proper diagnosis and management, especially in regions where the fungi are prevalent.
Causes & Symptoms
Clinical Causes: Exposure to airborne spores of Coccidioides fungi, usually through inhalation during activities like farming, construction, or outdoor recreation in endemic areas. Geographical factors: residing or traveling in arid regions like the southwestern United States, parts of Mexico, Central, and South America where the fungi are endemic. Infection in individuals with weakened immune systems, which may predispose them to atypical or disseminated forms. Rarely, reactivation of a previously dormant infection can lead to secondary manifestations.
Key Symptoms: Fever that persists or is recurrent Fatigue and malaise Chest pain or discomfort Cough, which may be dry or productive Muscle or joint aches Skin lesions such as nodules, ulcers, or rashes Bone pain or swelling if bones are involved Chronic cough or weight loss if dissemination occurs Symptoms specific to affected organ systems, such as neurological signs if the central nervous system is involved
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other forms of coccidioidomycosis involves a combination of clinical evaluation and laboratory testing. Common approaches include: - Serologic tests to detect antibodies against Coccidioides, such as complement fixation and immunodiffusion assays. - Microscopic examination of tissue samples or body fluids stained to reveal characteristic fungal structures. - Fungal cultures from affected tissues or fluids. - Imaging studies like X-rays, CT scans, or MRI scans to identify lesions in bones, the lungs, or the nervous system. - Histopathological examination to confirm tissue involvement and rule out other causes.
Treatment Protocols: Managing other forms of coccidioidomycosis typically involves antifungal medications tailored to the severity and location of the infection. Standard treatments include: - Azole antifungals such as fluconazole or itraconazole for mild to moderate infections. - Amphotericin B for severe or disseminated cases, especially when involving the central nervous system. - Duration of therapy may vary from several months to lifelong, depending on the persistence of infection and response. - Supportive care, including managing symptoms like pain or inflammation. - Regular monitoring through clinical assessments and laboratory tests to evaluate treatment effectiveness.
Clinical Advice & FAQs
Billing Guidance
Is B38.89 a billable ICD-10 code?
Yes, B38.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B38.89?
Clinical documentation must specify the nature of Other forms of coccidioidomycosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference